Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines

OK Bhattacharyya, BR Shah, GL Booth - Cmaj, 2008 - Can Med Assoc
Diabetes mellitus is a chronic condition that requires complex management; however, the
time of health care providers is limited and patient motivation varies. How can health care …

Diabetes: can we stop the time bomb?

M Fisher - Heart, 2003 - heart.bmj.com
Type 2 diabetes is increasing in prevalence and it is estimated that three million individuals
in the UK will have the disease by 2010. People with diabetes have a high risk of …

[HTML][HTML] Guideline approach to therapy in patients with newly diagnosed type 2 diabetes

I Raz - Diabetes care, 2013 - ncbi.nlm.nih.gov
Both the prevalence and incidence of type 2 diabetes are increasing worldwide in
conjunction with increased Westernization of the population's lifestyle. Type 2 diabetes is …

Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison

MD Kelsey, AJ Nelson, JB Green, CB Granger… - Journal of the American …, 2022 - jacc.org
Cardiovascular disease is a leading cause of morbidity and mortality in individuals with type
2 diabetes mellitus. These high-risk patients benefit from aggressive risk factor …

Cardiovascular risk management in type 2 diabetes: from clinical trials to clinical practice

K Cusi - The endocrinologist, 2001 - journals.lww.com
With diabetes in the United States reaching alarming proportions, reduction of
cardiovascular (CV) risk has become a unique challenge to health care providers. Recent …

Cardiovascular risk reduction in diabetes: underemphasised and overdue. Messages from major trials

AI Adler - Clinical Medicine, 2001 - ncbi.nlm.nih.gov
Diabetes markedly increases the risk of coronary artery disease and death, but is
underrecognised as a cardiovascular risk factor, despite the existence of effective …

Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registry

SV Arnold, K Gosch, M Kosiborod, ND Wong… - American Heart …, 2023 - Elsevier
Background Cardiovascular disease remains the primary source of morbidity and mortality
in type 2 diabetes (T2D). We characterized the change over time in the use of evidence …

[CITATION][C] 1. Strategies for improving care

American Diabetes Association - Diabetes care, 2016 - Am Diabetes Assoc
DIABETES CARE CONCEPTS In the following sections, different components of the clinical
management of patients with (or at risk for) diabetes are reviewed. Clinical practice …

Reducing cardiovascular disease risk in type 2 diabetes: is the focus on glycaemia warranted?

LD Ferguson, N Sattar - Diabetes, Obesity and Metabolism, 2013 - Wiley Online Library
Cardiovascular disease remains a major source of morbidity and mortality in type 2 diabetes
mellitus. This article examines the recent evidence from trials and related meta‐analyses on …

2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps

F Paneni - Diabetes and Vascular Disease Research, 2014 - journals.sagepub.com
Prevalence of diabetes and impaired glucose tolerance (IGT) is rapidly increasing, and the
World Health Organization (WHO) estimates a current worldwide prevalence of 346 million …